Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Marc Gitzinger

2PUBLICATIONS

41CO-AUTHORS

Medical devicesMedical molecular engineering of nucleic acids and proteins

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|May 04, 2022

The small-molecule SMARt751 reverses <i>Mycobacterium tuberculosis</i> resistance to ethionamide in acute and chronic mouse models of tuberculosis.

Marion Flipo, Rosangela Frita, Marilyne Bourotte

|Mar 18, 2017

Reversion of antibiotic resistance in <i>Mycobacterium tuberculosis</i> by spiroisoxazoline SMARt-420.

Nicolas Blondiaux, Martin Moune, Matthieu Desroses

Pageof 1

Frequent Collaborators

2 joint publications

Nicolas Willand

2 joint publications

Rosangela Frita

2 joint publications

Marion Flipo

2 joint publications

Vincent Delorme

2 joint publications

Kamel Djaout

2 joint publications

René Wintjens

2 joint publications

Alain R Baulard

2 joint publications

Benoit Déprez

2 joint publications

Priscille Brodin

1 joint publications

Martin Moune

Frequent Collaborators

2 joint publications

Nicolas Willand

2 joint publications

Rosangela Frita

2 joint publications

Marion Flipo

2 joint publications

Vincent Delorme

Top Related Videos

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular <em>Mycobacterium tuberculosis</em>

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular <em>Mycobacterium tuberculosis</em>

Published on : Apr 05, 2017

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged <em>Mycobacterium tuberculosis</em>

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged <em>Mycobacterium tuberculosis</em>

Published on : Mar 24, 2017

See more related videos

Top Related Videos

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular <em>Mycobacterium tuberculosis</em>

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular <em>Mycobacterium tuberculosis</em>

Published on : Apr 05, 2017

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged <em>Mycobacterium tuberculosis</em>

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged <em>Mycobacterium tuberculosis</em>

Published on : Mar 24, 2017

See more related videos